Mylan Must Face Narrowed EpiPen Class-Action Suit, Judge Rules

(Bloomberg) -- Mylan NV still has to fight a class-action suit over its EpiPen allergy treatment, though a judge narrowed its scope on Friday, throwing out allegations that the company made mislead...